Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenström's macroglobulinemia
Authors:
Open Access
- 13 February 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (7) , 1055-1058
Abstract
Key Points: STAT5 is constitutively phosphorylated in malignant B cells obtained from patients with Waldenström's macroglobulinemia. Inhibition of STAT5 signaling significantly decreases IgM production and may be useful therapeutically for patients with high IgM levels.Keywords
This publication has 20 references indexed in Scilit:
- Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activityBlood, 2011
- Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemiaJournal of Experimental Medicine, 2011
- Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cellsJournal of Biochemical and Molecular Toxicology, 2008
- Signal Transducer and Activator of Transcription 5b, c-Src, and Epidermal Growth Factor Receptor Signaling Play Integral Roles in Estrogen-Stimulated Proliferation of Estrogen Receptor-Positive Breast Cancer CellsMolecular Endocrinology, 2008
- Phosphorylated STAT5 Represents a New Possible Prognostic Marker in Hodgkin LymphomaAmerican Journal of Clinical Pathology, 2008
- Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration†Hepatology, 2007
- Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemiasBlood, 2006
- Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesisOncogene, 2006
- STAT5 and Oct-1 Form a Stable Complex That Modulates Cyclin D1 ExpressionMolecular and Cellular Biology, 2003
- Differential function of STAT5 isoforms in head and neck cancer growth controlOncogene, 2002